The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Cytokinetics
CYTK
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$57.32
1.07
1.90%
At Close: -
$57.32
0
0.00%
After Hours: 4:35 PM EDT
15 minutes delayed
Get Report
Comment
Cytokinetics (CYTK) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cytokinetics (NASDAQ:CYTK) Stock
Cytokinetics Stock (NASDAQ: CYTK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, August 22, 2024
Cytokinetics Unusual Options Activity For August 22
Benzinga Insights
Tuesday, August 13, 2024
Goldman Sachs Downgrades Cytokinetics to Neut...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Cytokin...
Benzinga Newsdesk
Friday, August 09, 2024
Needham Reiterates Buy on Cytokinetics, Maint...
Benzinga Newsdesk
Thursday, August 08, 2024
Cytokinetics Q2 2024 GAAP EPS $(1.31) Misses ...
Benzinga Newsdesk
Thursday, July 11, 2024
A Closer Look at Cytokinetics's Options Market Dynamics
Benzinga Insights
Monday, June 24, 2024
JP Morgan Maintains Overweight on Cytokinetic...
Benzinga Newsdesk
Monday, June 17, 2024
HC Wainwright & Co. Reiterates Buy on Cytokin...
Benzinga Newsdesk
Cytokinetics Has Dosed The First Participants...
Benzinga Newsdesk
Friday, June 07, 2024
Peering Into Cytokinetics's Recent Short Interest
Benzinga Insights
Wednesday, June 05, 2024
Cytokinetics Unusual Options Activity
Benzinga Insights
Cytokinetics shares are trading higher after ...
Benzinga Newsdesk
Cytokinetics Engaged In Acquisition Talks Wit...
Benzinga Newsdesk
Tuesday, June 04, 2024
B. Riley Securities Maintains Buy on Cytokine...
Benzinga Newsdesk
Friday, May 31, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wednesday, May 29, 2024
Truist Securities Maintains Buy on Cytokineti...
Benzinga Newsdesk
Tuesday, May 28, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, May 23, 2024
Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
Avi Kapoor
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
Vandana Singh
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Cytokine...
Benzinga Newsdesk
B of A Securities Maintains Neutral on Cytoki...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Gold Falls Sharply; US Composite PMI Surges In May
Avi Kapoor
Barclays Maintains Overweight on Cytokinetics...
Benzinga Newsdesk
Why Cytokinetics (CYTK) Shares Are Falling
Henry Khederian
Raymond James Maintains Outperform on Cytokin...
Benzinga Newsdesk
Market-Moving News for May 23rd
Benzinga Newsdesk
Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Needham Maintains Buy on Cytokinetics, Lowers...
Benzinga Newsdesk
Cytokinetics shares are trading lower after t...
Benzinga Newsdesk
VF Corp Posts Weak Q4 Results, Joins NetEase, Cytokinetics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Reported Earlier, Cytokinetics Prices Public ...
Benzinga Newsdesk
Wednesday, May 22, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Cytokinetics shares are trading lower after t...
Benzinga Newsdesk
Cytokinetics Plans Proposed Public Offering O...
Benzinga Newsdesk
Cytokinetics And Royalty Pharma Enter Funding...
Benzinga Newsdesk
Friday, May 17, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
'Amid Acquisition Speculation, Cytokinetics C...
Benzinga Newsdesk
Tuesday, May 14, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Cytokin...
Benzinga Newsdesk
Needham Reiterates Buy on Cytokinetics, Maint...
Benzinga Newsdesk
Monday, May 13, 2024
Cytokinetics Presents Additional Results From...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Cytokin...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Cytokinet...
Benzinga Newsdesk
Needham Reiterates Buy on Cytokinetics, Maint...
Benzinga Newsdesk
Wednesday, May 08, 2024
Cytokinetics Q1 2024 GAAP EPS $(1.33) Misses ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch